ClinicalTrials.gov record
Recruiting Phase 3 Interventional

Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk

ClinicalTrials.gov ID: NCT04774159

Public ClinicalTrials.gov record NCT04774159. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 8:24 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk: A Randomized Trial

Study identification

NCT ID
NCT04774159
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Population Health Research Institute
Other
Enrollment
6,150 participants

Conditions and interventions

Interventions

  • Colchicine 0.5 MG Oral Tablet Drug
  • Colchicine-Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 5, 2021
Primary completion
Nov 30, 2029
Completion
Nov 30, 2029
Last update posted
Mar 23, 2026

2021 – 2029

United States locations

U.S. sites
19
U.S. states
13
U.S. cities
17
Facility City State ZIP Site status
Yale School of Medicine New Haven Connecticut 06511 Recruiting
University of Florida - Gainesville Gainesville Florida 32611 Recruiting
Tampa General Hospital Tampa Florida 33606 Recruiting
University of Chicago Medical Center Chicago Illinois 60615 Recruiting
Henry Ford Health System Detroit Michigan 48202 Recruiting
Mayo Clinic Rochester Minnesota 55905 Recruiting
Rutgers University Newark New Jersey 07103 Recruiting
University of North Carolina at Chapel Hill Chapel Hill North Carolina 27599 Recruiting
Duke Regional Hospital Durham North Carolina 27704 Recruiting
Duke University Medical Center Durham North Carolina 27710 Recruiting
Duke Raleigh Hospital Raleigh North Carolina 27609 Recruiting
Ohio State University Wexner Medical Center Columbus Ohio 43210 Recruiting
Vanderbilt University Medical Center Nashville Tennessee 37232 Recruiting
Southwest Family Medicine Dallas Texas 75235 Recruiting
University of Texas Southwestern Medical Center Dallas Texas 75390 Recruiting
Texas Tech University Health Sciences Lubbock Texas 79430 Recruiting
Sentara Norfolk General Hospital Norfolk Virginia 23507 Recruiting
University of Washington Medical Center Seattle Washington 98195 Recruiting
Medical College of Wisconsin Milwaukee Wisconsin 53226 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 51 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04774159, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 23, 2026 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04774159 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →